Quote:
Originally Posted by wannabe
I would imagine that this would have no impact on symptoms since copaxone wasn't developed to impact symptoms at all, only slow the progression of the disease.
|
Probably simply a matter of semantics, but, if the disease progression is slowing, then sx manifestation will also be slowing/changing for the better. Mind showing me the source for your statement that C wasn't developed to impact sx?